Page 69 - Depression in adults: treatment and management
P. 69
Depression in adults: treatment and management (NG222)
1.13.2 Make sure people with depression who are going to have ECT are fully informed
of the risks, and of the risks and benefits specific to them. Take into account:
• the risks associated with a general anaesthetic
• any medical comorbidities
• potential adverse events, in particular cognitive impairment
• if the person is older, the possible increased risk associated with ECT treatment for
this age group
• the risks associated with not having ECT.
Document the assessment and discussion. [2022] [2022]
1.13.3 Discuss the use of ECT as a treatment option with the person with depression,
and reach a shared decision on its use based on their clinical needs and
preferences, if they have capacity to give consent. Take into account the
capacity of the person and the requirements of the Mental Health Act 2007 (if
applicable), and make sure:
• informed consent is given without pressure or coercion from the circumstances or
clinical setting
• the person is aware of their right to change their mind and withdraw consent at any
time
• there is strict adherence to recognised guidelines on consent, and advocates or carers
are involved to help informed discussions. [2022] [2022]
1.13.4 If a person with depression cannot give informed consent, only give ECT if it
does not conflict with a valid advance treatment decision the person made.
[2022] [2022]
1.13.5 For people whose depression has not responded well to ECT previously, only
consider a repeat trial of ECT after:
• reviewing the adequacy of the previous treatment course
• considering all other options
© NICE 2022. All rights reserved. Subject to Notice of rights (https://www.nice.org.uk/terms-and- Page 69 of
conditions#notice-of-rights). 103
